Finance

Lists
507789:BOM
Jagsonpal Pharmaceuticals Ltd
219,00 INR
-0,25%
(-0,55) 1D
16 ოქტ, 15:52:30 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 507789...
Open
219,55 INR
High
222,95 INR
Low
216,85 INR
Mkt. cap
14,44 მლრდ.
Avg. vol.
19,68 ათ.
Volume
1,65 ათ.
Dividend
1,14%
Quarterly dividend
0,63 INR
Ex-dividend date
4 სექ. 2026
P/E ratio
32,52
52-wk high
264,65 INR
52-wk low
154,90 INR
EPS
6,73 INR
Shares outstanding
26,20 მლნ.
No. of employees
1 ათ.
Open
219,55 INR
High
222,95 INR
Low
216,85 INR
Mkt. cap
14,44 მლრდ.
Avg. vol.
19,68 ათ.
Volume
1,65 ათ.
Dividend
1,14%
Quarterly dividend
0,63 INR
Ex-dividend date
4 სექ. 2026
P/E ratio
32,52
52-wk high
264,65 INR
52-wk low
154,90 INR
EPS
6,73 INR
Shares outstanding
26,20 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
4 საათის წინ
Understanding Momentum Shifts in (AGIX)
MarketBeat
MarketBeat
·
18 წუთის წინ
Scholastic (NASDAQ:SCHL) Raised to Hold at Wall Street Zen
Detroit Free Press
Detroit Free Press
·
19 საათის წინ
Memory-chip rout, inflation, CoreWeave: The week on Wall Street
About Jagsonpal Pharmaceuticals Ltd
CEO-
Employees1,3 ათ.
Founded1978
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
744,65 მლნ.
729,45 მლნ.
642,03 მლნ.
822,32 მლნ.
Cost of goods sold
272,28 მლნ.
264,53 მლნ.
249,67 მლნ.
286,24 მლნ.
Cost of revenue
272,28 მლნ.
264,53 მლნ.
249,67 მლნ.
286,24 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
165,46 მლნ.
172,95 მლნ.
397,81 მლნ.
227,78 მლნ.
Operating expense
331,89 მლნ.
326,10 მლნ.
303,96 მლნ.
385,10 მლნ.
Total operating expenses
604,17 მლნ.
590,63 მლნ.
553,63 მლნ.
671,34 მლნ.
Operating income
140,48 მლნ.
138,82 მლნ.
88,40 მლნ.
150,98 მლნ.
Other non operating income
30,27 მლნ.
29,75 მლნ.
-87,71 მლნ.
28,33 მლნ.
EBT including unusual items
168,10 მლნ.
145,21 მლნ.
117,56 მლნ.
176,80 მლნ.
EBT excluding unusual items
168,10 მლნ.
166,00 მლნ.
117,56 მლნ.
176,80 მლნ.
Income tax expense
42,36 მლნ.
35,70 მლნ.
29,94 მლნ.
44,91 მლნ.
Effective tax rate
25,20%
24,59%
25,47%
25,40%
Other operating expenses
126,28 მლნ.
126,45 მლნ.
-82,94 მლნ.
135,90 მლნ.
Net income
125,74 მლნ.
109,51 მლნ.
87,62 მლნ.
131,89 მლნ.
Net profit margin
16,89%
15,01%
13,65%
16,04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
117,43 მლნ.
-
Interest expense
-2,65 მლნ.
-2,57 მლნ.
-560,00 ათ.
-2,51 მლნ.
Net interest expenses
-2,65 მლნ.
-2,57 მლნ.
116,87 მლნ.
-2,51 მლნ.
Depreciation and amortization charges
23,86 მლნ.
23,86 მლნ.
23,19 მლნ.
21,42 მლნ.
EBITDA
164,18 მლნ.
155,55 მლნ.
108,00 მლნ.
174,59 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები